πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7361664

Vitamin D receptor antagonists and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7358377

Schweinfurthin analogues

The United States of America Β· Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7355012

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7354904

Bacteriocin inducer peptides

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7351435

Deglycosylated ricin toxin a-chain vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7351403

Sunscreen reagents from unsaturated waxes and triglycerides

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7348319

Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7341726

Modified HCV peptide immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7338807

Screening assays for compounds that cause apoptosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7335749

Tumor suppressor gene, p47Ing3

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7335356

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotei

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332645

IL-21 as a regulator of immunoglobin production

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332590

Molecular characteristics of non-small cell lung cancer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332172

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332170

Classical swine fever virus virulence determinant and a novel classical swine fever vaccin

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7330748

Method for determining in vivo concentration of a metabolite

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7329502

ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7320991

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7319091

Human derived monocyte attracting purified protein product useful in a method of treating

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7317086

Basal cell carcinoma tumor suppressor protein

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314632

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted